231 related articles for article (PubMed ID: 20975615)
1. The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in human immunodeficiency virus-infected children.
Taweesith W; Puthanakit T; Kowitdamrong E; Bunupuradah T; Wongngam W; Phasomsap C; Apornpong T; Bouko C; Pancharoen C
Pediatr Infect Dis J; 2011 Apr; 30(4):320-4. PubMed ID: 20975615
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1.
Armenian SH; Han JY; Dunaway TM; Church JA
Pediatr Infect Dis J; 2006 Apr; 25(4):368-70. PubMed ID: 16567993
[TBL] [Abstract][Full Text] [Related]
3. A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella.
Gershon AA; Levin MJ; Weinberg A; Song LY; LaRussa PS; Steinberg SP; Bartlett P;
Pediatr Infect Dis J; 2009 Jul; 28(7):653-5. PubMed ID: 19561431
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
[TBL] [Abstract][Full Text] [Related]
5. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells.
Levin MJ; Gershon AA; Weinberg A; Song LY; Fentin T; Nowak B;
J Infect Dis; 2006 Jul; 194(2):247-55. PubMed ID: 16779732
[TBL] [Abstract][Full Text] [Related]
6. Immunization of HIV-infected children with varicella vaccine.
Levin MJ; Gershon AA; Weinberg A; Blanchard S; Nowak B; Palumbo P; Chan CY;
J Pediatr; 2001 Aug; 139(2):305-10. PubMed ID: 11487761
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of postexposure immunization with live attenuated varicella vaccine in the household setting--a pilot study.
Mor M; Harel L; Kahan E; Amir J
Vaccine; 2004 Dec; 23(3):325-8. PubMed ID: 15530676
[TBL] [Abstract][Full Text] [Related]
8. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
[TBL] [Abstract][Full Text] [Related]
9. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
[TBL] [Abstract][Full Text] [Related]
10. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.
Hardy I; Gershon AA; Steinberg SP; LaRussa P
N Engl J Med; 1991 Nov; 325(22):1545-50. PubMed ID: 1658650
[TBL] [Abstract][Full Text] [Related]
11. Safety, Reactogenicity, and Immunogenicity of Human Rotavirus Vaccine RIX4414 in Human Immunodeficiency Virus-positive Infants in South Africa.
Steele AD; Madhi SA; Louw CE; Bos P; Tumbo JM; Werner CM; Bicer C; De Vos B; Delem A; Han HH
Pediatr Infect Dis J; 2011 Feb; 30(2):125-30. PubMed ID: 20842070
[TBL] [Abstract][Full Text] [Related]
12. Varicella vaccination in HIV-1-infected children after immune reconstitution.
Bekker V; Westerlaken GH; Scherpbier H; Alders S; Zaaijer H; van Baarle D; Kuijpers T
AIDS; 2006 Nov; 20(18):2321-9. PubMed ID: 17117018
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
Vesikari T; Baer M; Willems P
Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
[TBL] [Abstract][Full Text] [Related]
14. Study of tolerance and effectiveness of a varicella vaccine in leukemic children.
Bancillon A; Leblanc T; Baruchel A; Schaison G; Leverger G; Mallarmey D; Teuliere L
Nouv Rev Fr Hematol (1978); 1991; 33(6):555-6. PubMed ID: 1667953
[TBL] [Abstract][Full Text] [Related]
15. The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection.
Hammond O; Wang Y; Green T; Antonello J; Kuhn R; Motley C; Stump P; Rich B; Chirmule N; Marchese RD
J Med Virol; 2006 Dec; 78(12):1679-87. PubMed ID: 17063506
[TBL] [Abstract][Full Text] [Related]
16. Live attenuated varicella vaccine use in immunocompromised children and adults.
Gershon AA; Steinberg SP; Gelb L
Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
[TBL] [Abstract][Full Text] [Related]
17. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
American Academy of Pediatrics Committee on Infectious Diseases
Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582
[TBL] [Abstract][Full Text] [Related]
18. Prevention and treatment of VZV infections in patients with HIV.
Gershon AA
Herpes; 2001 Jul; 8(2):32-6. PubMed ID: 11867015
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of single dose live attenuated varicella vaccine (VR 795 Oka strain) in healthy Indian children: a randomized controlled study.
Mitra M; Faridi M; Ghosh A; Shah N; Shah R; Chaterjee S; Narang M; Bhattacharya N; Bhat G; Choudhury H; Kadhe G; Mane A; Roy S
Hum Vaccin Immunother; 2015; 11(2):443-9. PubMed ID: 25692656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]